Literature DB >> 20207874

Annual burden of ocular toxoplasmosis in the US.

Jeffrey L Jones1, Gary N Holland.   

Abstract

Toxoplasmosis is the most common retinal infection in the United States, and it can severely impact vision. We used data from population-based studies, outbreaks, and the U.S. census to estimate the burden of Toxoplasma gondii infection and ocular toxoplasmosis. We estimate that 1,075,242 persons are infected with T. gondii, 21,505 persons have ocular lesions (both asymptomatic and symptomatic), and 4,839 (range = 2,150-7,527) persons develop symptomatic ocular toxoplasmosis each year in the United States. Toxoplasmosis contributes a significant burden to eye disease in the United States.

Entities:  

Mesh:

Year:  2010        PMID: 20207874      PMCID: PMC2829910          DOI: 10.4269/ajtmh.2010.09-0664

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  13 in total

Review 1.  Genetic analysis of the diversity in Toxoplasma gondii.

Authors:  Marie-Laure Dardé
Journal:  Ann Ist Super Sanita       Date:  2004       Impact factor: 1.663

2.  Outbreak of toxoplasmosis associated with municipal drinking water. The BC Toxoplasma Investigation Team.

Authors:  W R Bowie; A S King; D H Werker; J L Isaac-Renton; A Bell; S B Eng; S A Marion
Journal:  Lancet       Date:  1997-07-19       Impact factor: 79.321

3.  Unusual abundance of atypical strains associated with human ocular toxoplasmosis.

Authors:  M E Grigg; J Ganatra; J C Boothroyd; T P Margolis
Journal:  J Infect Dis       Date:  2001-07-24       Impact factor: 5.226

4.  Ophthalmic survey of a community. 1. Abnormalities of the ocular fundus.

Authors:  R E Smith; J P Ganley
Journal:  Am J Ophthalmol       Date:  1972-12       Impact factor: 5.258

5.  Toxoplasma gondii infection in the United States: seroprevalence and risk factors.

Authors:  J L Jones; D Kruszon-Moran; M Wilson; G McQuillan; T Navin; J B McAuley
Journal:  Am J Epidemiol       Date:  2001-08-15       Impact factor: 4.897

Review 6.  Preventing congenital toxoplasmosis.

Authors:  A Lopez; V J Dietz; M Wilson; T R Navin; J L Jones
Journal:  MMWR Recomm Rep       Date:  2000-03-31

7.  An update on current practices in the management of ocular toxoplasmosis.

Authors:  Gary N Holland; Kevan G Lewis
Journal:  Am J Ophthalmol       Date:  2002-07       Impact factor: 5.258

Review 8.  Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis.

Authors:  Georgios Pappas; Nikos Roussos; Matthew E Falagas
Journal:  Int J Parasitol       Date:  2009-05-09       Impact factor: 3.981

9.  Ocular toxoplasmosis: a global reassessment. Part I: epidemiology and course of disease.

Authors:  Gary N Holland
Journal:  Am J Ophthalmol       Date:  2003-12       Impact factor: 5.258

10.  Genetic divergence of Toxoplasma gondii strains associated with ocular toxoplasmosis, Brazil.

Authors:  Asis Khan; Catherine Jordan; Cristina Muccioli; Adriana L Vallochi; Luiz V Rizzo; Rubens Belfort; Ricardo W A Vitor; Claudio Silveira; L David Sibley
Journal:  Emerg Infect Dis       Date:  2006-06       Impact factor: 6.883

View more
  48 in total

1.  Towards an immunosense vaccine to prevent toxoplasmosis: protective Toxoplasma gondii epitopes restricted by HLA-A*0201.

Authors:  Hua Cong; Ernest J Mui; William H Witola; John Sidney; Jeff Alexander; Alessandro Sette; Ajesh Maewal; Rima McLeod
Journal:  Vaccine       Date:  2010-11-21       Impact factor: 3.641

2.  Toxoplasmosis: new challenges for an old disease.

Authors:  B Bodaghi; V Touitou; C Fardeau; L Paris; P LeHoang
Journal:  Eye (Lond)       Date:  2012-01-06       Impact factor: 3.775

3.  Understanding Toxoplasmosis in the United States Through "Large Data" Analyses.

Authors:  Joseph Lykins; Kanix Wang; Kelsey Wheeler; Fatima Clouser; Ashtyn Dixon; Kamal El Bissati; Ying Zhou; Christopher Lyttle; Andrey Rzhetsky; Rima McLeod
Journal:  Clin Infect Dis       Date:  2016-06-26       Impact factor: 9.079

4.  Seroprevalence of Toxoplasma gondii in White-Tailed Deer (Odocoileus virginianus) and Free-Roaming Cats (Felis catus) Across a Suburban to Urban Gradient in Northeastern Ohio.

Authors:  Gregory A Ballash; J P Dubey; O C H Kwok; Abigail B Shoben; Terry L Robison; Tom J Kraft; Patricia M Dennis
Journal:  Ecohealth       Date:  2014-10-01       Impact factor: 3.184

5.  Pyrimidine Pathway-Dependent and -Independent Functions of the Toxoplasma gondii Mitochondrial Dihydroorotate Dehydrogenase.

Authors:  Miryam Andrea Hortua Triana; Daniela Cajiao Herrera; Barbara H Zimmermann; Barbara A Fox; David J Bzik
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

6.  Ocular Toxoplasmosis: Controversies in Primary and Secondary Prevention.

Authors:  Norman A Saffra; Carly J Seidman; Louis M Weiss
Journal:  J Neuroinfect Dis       Date:  2013

7.  Congenital Toxoplasmosis.

Authors:  James B McAuley
Journal:  J Pediatric Infect Dis Soc       Date:  2014-09       Impact factor: 3.164

8.  Repurposing the open access malaria box to discover potent inhibitors of Toxoplasma gondii and Entamoeba histolytica.

Authors:  Fabrice F Boyom; Patrick V T Fokou; Lauve R Y Tchokouaha; Thomas Spangenberg; Alvine N Mfopa; Ruffin M T Kouipou; Cedric J Mbouna; Valerie F Donkeng Donfack; Paul H A Zollo
Journal:  Antimicrob Agents Chemother       Date:  2014-07-21       Impact factor: 5.191

Review 9.  The impact of the waterborne transmission of Toxoplasma gondii and analysis efforts for water detection: an overview and update.

Authors:  Panagiotis Karanis; Hebatalla M Aldeyarbi; Marzieh E Mirhashemi; Khalil M Khalil
Journal:  Environ Sci Pollut Res Int       Date:  2012-09-19       Impact factor: 4.223

10.  Toxoplasma gondii seroprevalence in the United States 2009-2010 and comparison with the past two decades.

Authors:  Jeffrey L Jones; Deanna Kruszon-Moran; Hilda N Rivera; Courtney Price; Patricia P Wilkins
Journal:  Am J Trop Med Hyg       Date:  2014-04-07       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.